European Council agrees on SPC manufacturing waiver
The European Council has reached a political agreement on a proposal for the supplementary protection certificate manufacturing waiver for patent-protected pharmaceuticals.
EU court rejects Bayer’s heart-related TM
Bayer suffered defeat at the hands of the EU General Court today, with the rejection of its attempt to register what the court deemed to be heart-related trademark.
Tough year ahead as generics take bite out of market: Teva
Israel-based Teva has predicted 2019 will be a tough year, with lower revenue and profit, as the company faces generic competition for two of its top-selling drugs.
EU court throws out dentistry TM application
The EU General Court has dismissed an appeal from German company Nemius Group against a decision to refuse registration for its ‘Dentaldisk’ mark.
Boehringer Ingelheim teams up with IBM to explore blockchain
The Canadian units of IBM and pharmaceutical company Boehringer Ingelheim have united to explore the use of blockchain technology in clinical trials.
Roche agrees to pay $21m to settle Enzo infringement suit
Swiss pharmaceutical company Roche Diagnostics has agreed to pay $21 million as part of a settlement to a patent infringement case with New York-based Enzo Biochem.
Pharma group asks USTR to drop India from watch list
The lobby group for India’s pharma industry has asked the US Trade Representative office to remove India from its Priority Watch List of places that have weak enforcement of intellectual property laws.
Clarivate announces new Life Science Alliances programme
Global information company Clarivate Analytics has launched a “Life Science Alliances Program” to provide drug and medical device developers a new way to advance their research and development.
UK could lose out on Europe-wide drug safety system post-Brexit
UK patients could be more exposed to counterfeit medicines than EU patients in the event of a ‘no deal’ Brexit, because access to an initiative aimed at protecting patients from fake drugs could be lost.
Dutch company’s patent for Ethiopian grain annulled
A long running dispute between two Dutch companies over ownership of methods for the processing of teff, a grain cultivated in Ethiopia, has been settled in the Court of The Hague.
